In harmony with this assumption, SOCS-3 expression has been shown to increase during development and progression of prostate cancer [45] and enhances glioblastoma cell survival, its loss converting the anti-apoptotic function of STAT-3 into pro-apoptotic [46]. The gene discussed is SOCS3; the disease is prostate cancer.